Varex Imaging (NASDAQ:VREX) Releases Q1 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $(0.05)-$0.10 for the period, compared to the consensus estimate of $0.02. The company issued revenue guidance of $195-215 million, compared to the consensus revenue estimate of $186.50 million.

Varex Imaging Price Performance

NASDAQ:VREX traded up $0.44 during mid-day trading on Tuesday, hitting $14.56. 1,202,387 shares of the company’s stock traded hands, compared to its average volume of 489,282. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.89 and a current ratio of 3.34. The firm’s 50 day simple moving average is $12.35 and its 200 day simple moving average is $13.46. Varex Imaging has a 1 year low of $10.19 and a 1 year high of $21.50. The company has a market cap of $595.50 million, a PE ratio of 19.89 and a beta of 0.53.

Analyst Upgrades and Downgrades

Separately, B. Riley initiated coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They set a “buy” rating and a $21.00 price target on the stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.